Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 22Gynecologic 5Other hematologic neoplasm 3Lymphoid 3Genitourinary 3Thoracic 2Plasma cell 2Myeloid 2Dermatologic 2CNS 2Other solid neoplasm 1Other 1Head & Neck 1Gastrointestinal 1

Conditions

Obesity 1Breast Neoplasms 1Body Weight Changes 1

Interventions

Exercise 9exemestane 4Psychiatric Rehabilitation 4Tamoxifen 3Methods 3Metformin 3Letrozole 3Early Intervention, Educational 3Diet Therapy 3Bupropion 3Bariatric Surgery 3Anastrozole 3Vitamin D 2Therapeutics 2Sugars 2Specimen Handling 2Naltrexone 2Mammography 2Diet, Mediterranean 2Counseling 2Cognitive Behavioral Therapy 2Cholecalciferol 2Blood Specimen Collection 2rosiglitazone-metformin combination 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Yoga 1Walking 1Tirzepatide 1Testosterone Propionate 1Testosterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Immunoenzyme Techniques × Other × Clear all
NCT00859989 2013-12-18

A Weight-Loss Program in Helping Obese Black Women Lose Weight

National Cancer Institute (NCI)

Phase 3 Unknown
200 enrolled
BreastOther

Body Weight Changes, Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡